Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer

被引:10
|
作者
Cheng, David [1 ,2 ]
Dumontier, Clark [2 ,3 ,4 ]
Sheikh, Ayesha R. [5 ]
La, Jennifer [3 ]
Brophy, Mary T. [3 ,6 ]
Do, Nhan, V [3 ,6 ]
Driver, Jane A. [2 ,3 ,6 ,7 ]
Tuck, David P. [3 ,6 ]
Fillmore, Nathanael R. [2 ,3 ,7 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] VA Boston Healthcare Syst, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
[5] St Vincent Hosp, Worcester, MA 01604 USA
[6] Boston Univ, Boston, MA 02215 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
来源
CANCER MEDICINE | 2022年 / 11卷 / 15期
关键词
electronic health records; frailty; non-small cell lung; prognosis; veterans; COMPREHENSIVE GERIATRIC ASSESSMENT; CARE; ONCOLOGY; ACCUMULATION; MORTALITY; CONSENSUS; SURVIVAL; CURVES; ADULTS;
D O I
10.1002/cam4.4658
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Older patients with non-small cell lung cancer (NSCLC) are a heterogeneous population with varying degrees of frailty. An electronic frailty index such as the Veterans Affairs Frailty Index (VA-FI) can potentially help identify vulnerable patients at high risk of poor outcomes. Methods NSCLC patients >= 65 years old and diagnosed in 2002-2017 were identified using the VA Central Cancer Registry. The VA-FI was calculated using administrative codes from VA electronic health records data linked with Medicare and Medicaid data. We assessed associations between the VA-FI and times to mortality, hospitalization, and emergency room (ER) visit following diagnosis by Kaplan-Meier analysis and multivariable stratified Cox models. We also evaluated the change in discrimination and calibration of reference prognostic models after adding VA-FI. Results We identified a cohort of 42,204 older NSCLC VA patients, in which 55.5% were classified as frail (VA-FI >0.2). After adjustment, there was a strong association between VA-FI and the risk of mortality (HR = 1.23 for an increase of four deficits or, equivalently, an increase of 0.129 on VA-FI, p < 0.001), hospitalization (HR = 1.16 for four deficits, p < 0.001), and ER visit (HR = 1.18 for four deficits, p < 0.001). Adding VA-FI to baseline prognostic models led to statistically significant improvements in time-dependent area under curves and did not have a strong impact on calibration. Conclusion Older NSCLC patients with higher VA-FI have significantly elevated risks of mortality, hospitalizations, and ER visits following diagnosis. An electronic frailty index can serve as an accessible tool to identify patients with vulnerabilities to inform clinical care and research.
引用
收藏
页码:3009 / 3022
页数:14
相关论文
共 50 条
  • [21] Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer
    Xu, Chun-Hua
    Wang, Wei
    Lin, Yong
    Qian, Li-Hua
    Zhang, Xiu-Wei
    Wang, Qing-Bo
    Yu, Li-Ke
    ONCOTARGET, 2017, 8 (12) : 18746 - 18753
  • [22] Prognostic value of MRP, LRP and P-gp in patients with non-small cell lung cancer
    Liu, Zhigang
    Sun, Ruifang
    Zhang, Juan
    Ding, Caixia
    Ma, Gang
    Zhao, Xinliang
    Lu, Weidong
    Wang, Xiang
    Dang, Chengxue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (06): : 6799 - +
  • [23] SPARC expression and prognostic value in non-small cell lung cancer
    Huang, Yan
    Zhang, Jing
    Zhao, Yuan-Yuan
    Jiang, Wei
    Xue, Cong
    Xu, Fei
    Zhao, Hong-Yun
    Zhang, Yang
    Zhao, Li-Ping
    Hu, Zhi-Huang
    Yao, Zhi-Wen
    Liu, Qian-Yong
    Zhang, Li
    CHINESE JOURNAL OF CANCER, 2012, 31 (11) : 541 - 548
  • [24] Prognostic value of angiogenesis in operable non-small cell lung cancer
    Giatromanolaki, A
    Koukourakis, M
    OByrne, K
    Fox, S
    Whitehouse, R
    Talbot, DC
    Harris, AL
    Gatter, KC
    JOURNAL OF PATHOLOGY, 1996, 179 (01): : 80 - 88
  • [25] Prognostic Value of the Geriatric Nutritional Risk Index in Non-Small Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis
    Wang, Haoyu
    Li, Cui
    Yang, Ruiyuan
    Jin, Jing
    Liu, Dan
    Li, Weimin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] A new PET/CT volumetric prognostic index for non-small cell lung cancer
    Zhang, Hao
    Wroblewski, Kristen
    Jiang, Yulei
    Penney, Bill C.
    Appelbaum, Daniel
    Simon, Cassie A.
    Salgia, Ravi
    Pu, Yonglin
    LUNG CANCER, 2015, 89 (01) : 43 - 49
  • [27] Prognostic Value of the Geriatric Nutritional Risk Index in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis
    Sun, Xin-Yu
    Lin, Yu
    Guo, Wei
    Yin, Xiao-Ming
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (10): : 3623 - 3633
  • [28] Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
    Holgersson, Georg
    Sandelin, Martin
    Hoye, Even
    Bergstrom, Stefan
    Henriksson, Roger
    Ekman, Simon
    Nyman, Jan
    Helsing, Martin
    Friesland, Signe
    Holgersson, Margareta
    Lundstrom, Kristina Lamberg
    Janson, Christer
    Birath, Elisabet
    Morth, Charlotte
    Blystad, Thomas
    Ewers, Sven-Borje
    Loden, Britta
    Bergqvist, Michael
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3176 - 3182
  • [29] Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
    Wang, Yi
    Lei, Yu
    Zheng, Delai
    Yang, Yanhui
    Luo, Lei
    Li, Ji
    Xie, Xiaoyang
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
  • [30] Prognostic impact of serum transthyretin in patients with non-small cell lung cancer
    Shimura, Tatsuo
    Shibata, Masahiko
    Inoue, Takuya
    Owada-Ozaki, Yuki
    Yamaura, Takumi
    Muto, Satoshi
    Hasegawa, Takeo
    Shio, Yutaka
    Suzuki, Hiroyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (06) : 597 - 604